or Try an Advanced Search...

    Tyrosine Kinase Stocks List

    Symbol Grade Name % Change
    EXEL B Exelixis, Inc. 2.24
    RIGL B Rigel Pharmaceuticals, Inc. 3.99
    KALA C Kala Pharmaceuticals, Inc. 3.74
    BPMC C Blueprint Medicines Corporation -2.56
    AVBP C ArriVent BioPharma, Inc. 3.23
    PBYI C Puma Biotechnology Inc 3.45
    NRIX D Nurix Therapeutics, Inc. -1.43
    COGT D Cogent Biosciences, Inc. 1.67
    KRON F Kronos Bio, Inc. 3.28
    BBIO F BridgeBio Pharma, Inc. 0.77
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Cancer Protein Kinase Inhibitor Biopharmaceutical Biotechnology Enzymes Receptor Tyrosine Kinase Tyrosine Kinase Receptors Chemical Compounds Daiichi Sankyo Fibroblast Growth Factor Receptor Gastrointestinal Gastrointestinal Stromal Tumor Mastocytosis Non Small Cell Lung Cancer Ophthalmic Organ Systems Small Molecule Therapies Solid Tumors Systemic Mastocytosis Treatment Of Cancer

    Related ETFs - A few ETFs which own one or more of the above listed Tyrosine Kinase stocks.

    Symbol Grade Name Weight
    IDNA F iShares Genomics Immunology and Healthcare ETF 9.71
    CANC F Tema Oncology ETF 9.08
    PBE C PowerShares Dynamic Biotech & Genome 6.77
    BBP C BioShares Biotechnology Products Fund 4.94
    CNCR F Loncar Cancer Immunotherapy ETF 4.77
    View all Tyrosine Kinase ETFs...
    Compare ETFs
    Compare CANC to PBE Compare IDNA to PBE Compare PBE to CNCR

        Tyrosine Kinase Stocks Recent News

        Date Stock Title
        Nov 23 BBIO Attruby™ (acoramidis), a Near Complete TTR Stabilizer (≥90%), approved by FDA to Reduce Cardiovascular Death and Cardiovascular-related Hospitalization in ATTR-CM Patients
        Nov 22 KRON Deal Dispatch: Starbucks Considers China Sale, Private Equity Bankrupts Snack Company, Darwin Financial Talks Mining
        Nov 21 BBIO Why Is BridgeBio Pharma, Inc. (BBIO) Among the Worst Performing Biotech Stocks in 2024?
        Nov 21 EXEL 3 Reasons Growth Investors Will Love Exelixis (EXEL)
        Nov 21 PBYI PBYI Begins Phase II Study on Alisertib Combo in Breast Cancer
        Nov 21 PBYI Puma commences Phase II trial of alisertib for breast cancer treatment
        Nov 20 NRIX Nurix Therapeutics Receives PRIME Designation from the European Medicines Agency for NX-5948 for the Treatment of Relapsed or Refractory Chronic Lymphocytic Leukemia
        Nov 20 PBYI Puma Biotechnology Announces Initiation of ALISCA™-Breast1 Phase II Trial of Alisertib in Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer
        Nov 20 EXEL Zacks.com featured highlights Amazon, Maplebear, Exelixis and Doximity
        Nov 19 BBIO BridgeBio Pharma's Acoramidis Shows Competitive Edge Against Pfizer's Tafamidisa In Lucrative But Competitive ATTR-CM Market
        Nov 19 RIGL How Much Upside is Left in Rigel (RIGL)? Wall Street Analysts Think 28.28%
        Nov 19 BBIO The Consensus EPS Estimates For BridgeBio Pharma, Inc. (NASDAQ:BBIO) Just Fell Dramatically
        Nov 19 RIGL Zacks.com featured highlights Rigel, Synchrony Financial, SkyWest, Allient and Rush Street Interactive
        Nov 18 RIGL 5 Relative Price Strength Options Available for Investors
        Nov 18 BBIO Open-Label Extension Data Confirms Sustained Benefit of Acoramidis on Cardiovascular Outcomes, Including Statistically Significant Reduction in ACM Within 36 Months
        Nov 18 BBIO BridgeBio Pharma Announces Publication in the New England Journal of Medicine of Phase 2 PROPEL 2 Study of Infigratinib for Children Living with Achondroplasia
        Related Industries: Biotechnology
        Related Stock Lists: Cancer Protein Kinase Inhibitor Biopharmaceutical Biotechnology Enzymes Receptor Tyrosine Kinase Tyrosine Kinase Receptors Chemical Compounds Daiichi Sankyo Fibroblast Growth Factor Receptor Gastrointestinal Gastrointestinal Stromal Tumor Mastocytosis Non Small Cell Lung Cancer Ophthalmic Organ Systems Small Molecule Therapies Solid Tumors Systemic Mastocytosis Treatment Of Cancer
        Tyrosine Kinase

        Tyrosine kinase is an enzyme that catalyzes the transfer of phosphate groups from ATP to tyrosine residues on proteins. It is involved in many cellular processes, including cell growth, differentiation, and migration. Tyrosine kinases are also involved in signal transduction pathways, which are important for cell communication and regulation. Mutations in tyrosine kinases can lead to cancer and other diseases.

        Browse All Tags